GlobeNewswire

Fentress Architects: The Future of Airports as Civic Spaces

Dela

The European Cultural Centre and Global Art Affairs Foundation invited Fentress Architects and North Carolina State University College of Design to participate in the 2018 Venice Architecture Biennale May 26-November 25, 2018, at the historic Palazzo Bembo.

 

Denver, Colo. - May 21, 2018, May 21, 2018 (GLOBE NEWSWIRE) --

Architecture students from North Carolina State University College of Design will join Fentress at the Palazzo Bembo to present their designs for airports of the future. Fentress has been guiding students in preparation for the exhibition, which allows 11 students to embark on a once-in-a-lifetime opportunity to travel to Italy for the 2018 Venice Biennale of Architecture. Their designs will be featured in the "Time Space Existence" exhibit, offering the public a glimpse at the future of airport design. The students are participating in an Airport Design course with Principal in Charge of Design Curt Fentress, FAIA, RIBA, and Alumni Distinguished Professor of Architecture Wayne Place, Ph.D. that focuses on designing airports that reflect the context and culture of their location.

Fentress helped create the NC State University College of Design airport design studio in 2013. The studio focuses on airports as a building type that establishes civic spaces. Students are challenged to design airports for various locations around the world. As part of this process, student design teams research the culture, climate, and terrain of their chosen location. By the end of the course, students know how to implement flexible design strategies to create world-class airports that reflect a sense of place.

Curt Fentress, FAIA, RIBA, is an alumnus and valuable supporter of the College of Design. "It's very exciting to see how these architectural minds are transforming the future of airport design," says Curt Fentress. Graduate student Cameron Westbrook, who is currently participating in the studio, says, "It's been a good experience to work with Fentress Architects. It's been eye-opening because there's so much technology and so much planning to incorporate within the early stages of designing an airport. It can be overwhelming, but it also puts us in a position to want to know more. They [Fentress] are also very encouraging."

Invited by the European Cultural Centre and Global Art Affairs Foundation, Fentress Architects will return to the 2018 Venice Biennale of Architecture to present Now Boarding - Fentress Architects: Airports as Civic Spaces. Fentress made its debut at the Biennale in 2016 with its Now Boarding exhibition, celebrating the past, present, and future of airport design. This year the firm's exhibition will feature airports as civic spaces, showcasing the concept of humanism flowing through airports. Through the use of film, photographs, and models, the exhibition showcases the transformation of the passenger experience in contemporary airport design. The concept of airports as civic spaces is explored through Fentress designs for five airport terminals:

·  South Terminal Complex at Orlando International Airport (MCO)

·  Incheon International Airport (ICN)

·  Seattle-Tacoma International Airport (SEA)

·  Denver International Airport (DEN)

·  Tom Bradley International Terminal at Los Angeles International Airport (LAX)

About the Biennale

The Venice Biennale is one of the most prestigious international cultural events in the world. By inviting the world's leading design thinkers, visionaries, and makers, the Biennale consistently cultivates a progressive voice that inspires, advocates, and connects a global audience. The Biennale and associated exhibitions are hosted throughout the island of Venice, imbuing the city's historic past as an international center for arts and culture with modern significance, while maintaining Venice's status as a premier destination. All told, over a quarter million people visited the last Architecture Biennale, with millions more accessing the exhibition via press and other media.

About Palazzo Bembo

Now Boarding - Fentress Architects: Airports as Civic Spaces and the College of Design exhibition will be featured at the historic Palazzo Bembo, overlooking the Grand Canal and just steps from the centrally-located Rialto Bridge. The Palazzo was built by the noble Bembo family in the 15th century, and its architectural style reflects the Venetian influences of its original period and those from subsequent restorations. Among the ancient families of Venetian aristocracy, the Bembo lineage includes saints, leaders, heroes, and writers. The Bembo font, a popular serif typeface, traces its origins to the family.

About the North Carolina State College of Design

The NC State College of Design prepares students for a career in design through interdisciplinary engagement, innovative exploration of technologies, and a core foundation of design thinking and practice. The College of Design offers undergraduate, graduate, Doctor of Design [DDes], and Ph.D. in design degrees and currently has 850 enrolled students. NC State University is a leading public research university located in Raleigh, North Carolina. In response to an ever-expanding global interest in all disciplines of design, the College's curriculum incorporates relevant practices reflecting both the University's research, its number one status in the state, and its land-grant mission. Effective design requires attention and sensitivity to the social, economic, political, cultural, and behavioral understanding of the environment and people. Our graduate and undergraduate programs in Architecture, Art + Design, Design Studies, Graphic Design, Industrial Design, and Landscape Architecture are intended to de­velop a designer's perception, knowledge, skills, and problem-solving abilities to develop design solutions for public interest, to serve the needs of all users, and to impact the myriad of sustainability and life-quality problems across the globe.

design.ncsu.edu
 
 
Fentress Architects is a global design firm that passionately pursues the creation of sustainable and iconic architecture. Together with its clients, Fentress creates inspired design to improve the human environment. Founded by Curtis Fentress in 1980, the firm has designed $42 billion of architectural projects worldwide, visited by more than 550 million people each year. Fentress is a dynamic learning organization, driven to grow its ability to design, innovate and exceed client expectations. The firm has been honored with more than 500 distinctions for design excellence and innovation.

Fentress has studios in Denver, Colorado; Washington, D.C.; Los Angeles and San Francisco, California; and London, U.K. www.fentressarchitects.com

Attachments

Julian Fentress
Fentress Architects
303 698 7298
jfentress@fentressarchitects.com
 



This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Fentress Architects via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Immunicum AB (publ) Announces Upcoming Investor Events in October and November22.10.2018 16:00Pressmeddelande

Press Release 22 October 2018 Immunicum AB (publ) Announces Upcoming Investor Events in October and November Immunicum AB (publ; IMMU.ST) announced today that the Company will participate in and host investor events in October and November. At all events Carlos de Sousa, CEO of Immunicum, and other members of the management team, will provide a corporate presentation and be available for a question and answer session. BioStock Life Science Summit Date: October 25, 2018 Presentation Time: 18.50 Central European Time Venue: Medicon Village, Scheelevägen 2, Building 302-auditorium, Lund, Sweden Registration Link: https://www.eventbrite.com/e/biostock-life-science-summit-tickets-51114333347 Immunicum Investor Event - Gothenburg Date: October 29, 2018 Presentation Time: 17.30 - 20.00 Central European Time Venue: First Hotel G, Nils Ericsonplatsen, 411 03 Gothenburg, Sweden Immunicum Investor Event - Stockholm Date: October 30, 2018 Presentation Time: 17.30 - 20.00 Central European Time Venu

Immunicum AB (publ) meddelar kommande investerarevent under oktober och november22.10.2018 16:00Pressmeddelande

Pressmeddelande 22 oktober 2018 Immunicum AB (publ) meddelar kommande investerarevent under oktober och november Immunicum AB (publ; IMMU.ST) meddelar i dag att bolaget kommer att anordna och delta i investerarträffar under oktober och november. Vid samtliga event kommer Carlos de Sousa, Immunicums VD, och övriga medlemmar av ledningsgruppen, att hålla en presentation av bolaget och vara tillgängliga för att svara på frågor. BioStock Life Science Summit Datum: 25 oktober 2018 Presentationstid: Kl. 18.50 CET Plats: Medicon Village, Scheelevägen 2, byggnad 302 - hörsalen, Lund Länk för registrering: https://www.eventbrite.com/e/biostock-life-science-summit-tickets-51114333347 Immunicums investerarevent - Göteborg Datum: 29 oktober 2018 Presentationstid: Kl. 17.30 - 20.00 CET Plats: First Hotel G, Nils Ericsonplatsen, 411 03, Göteborg Immunicums investerarevent - Stockholm Datum: 30 oktober 2018 Presentationstid: Kl. 17.30 - 20.00 CET Plats: Ingenjörshuset Citykonferensen, Plan 1, Malmski

Immunicum AB (publ) presenterar prekliniska resultat för ilixadencel i kombination med checkpointhämmare och immunaktiverare på 2018 års ESMO-kongress22.10.2018 12:45Pressmeddelande

Pressmeddelande 22 oktober 2018 Immunicum AB (publ) presenterar prekliniska resultat för ilixadencel i kombination med checkpointhämmare och immunaktiverare på 2018 års ESMO-kongress -- Intratumoral behandling med ilixadencel, en cellbaserad, lagringsbar immunaktiverare, ger en synergistisk antitumöreffekt och förstärker effekten av behandling med anti-PD-1 och anti-CD137 i djurmodeller -- Immunicum AB (publ; IMMU.ST) presenterar under 2018 års ESMO kongress (European Society for Medical Oncology) prekliniska resultat som visar en synergistisk anti-tumöreffekt när bolagets ledande produkt ilixadencel ges i kombination med en checkpointhämmare eller immunaktiverare. Resultaten från studien, som presenteras på en poster, visar att intratumoralt administrerat ilixadencel kan förstärka anti-tumörsvar och överlevnad vid behandling med checkpointhämmare eller immunaktiverare. Detta visar på potentialen hos ilixadencel att bli en komplementerande verkningsmekanism till flera olika framtida im

Immunicum AB (publ) Presents Preclinical Results of Ilixadencel in Combination with Checkpoint Inhibitors and Immune Enhancers at ESMO 201822.10.2018 12:45Pressmeddelande

Press Release 22 October 2018 Immunicum AB (publ) Presents Preclinical Results of Ilixadencel in Combination with Checkpoint Inhibitors and Immune Enhancers at ESMO 2018 -- Intratumoral treatment with ilixadencel, an off-the-shelf cell-based immune primer, provides synergistic anti-tumor effect and enhances efficacy of anti-PD-1 and anti-CD137 treatment in animal model -- Immunicum AB (publ; IMMU.ST) announced today the presentation of preclinical results that showed anti-tumor synergy between its lead product ilixadencel and a checkpoint inhibitor or an immune enhancer in a poster at the European Society for Medical Oncology (ESMO) 2018 Congress. The results of the study highlight the ability of intratumoral ilixadencel to enhance anti-tumor response and survival of systemic checkpoint inhibitors (anti-PD-1) or immune enhancers (anti-CD137/4-1BB). This emphasizes the potential for ilixadencel in multiple future immuno-oncology combination strategies by incorporating complementary mech

Karolinska Development's portfolio company OssDsign announces FDA clearance for Cranioplug22.10.2018 09:00Pressmeddelande

STOCKHOLM, October 22, 2018. Karolinska Development's portfolio company OssDsign announces that its latest product Cranioplug has received 510(k) clearance by the FDA, which allows marketing and sales of the product in US. The implant is the first product of its kind in the US market. Cranioplug is an implant used during neurosurgical procedures. The product is intended to cover and plug holes drilled into the skull during surgery and to reattach cranial bone removed during surgery. Cranioplug resorbs and is replaced with bone during the healing process. Anders Lundqvist, CEO of OssDsign, said: "Receiving clearance for Cranioplug is an important step for OssDsign. This motivates us to increase our presence in the US market and continue to build our US organization throughout 2018 and beyond. The regenerative features of OssDsign's calcium phosphate composition are now getting recognized, and it's our mission to turn them into real benefits for patients, surgeons and hospital systems."

Karolinska Development's portfolio company OssDsign announces FDA clearance for Cranioplug22.10.2018 09:00Pressmeddelande

STOCKHOLM, October 22, 2018. Karolinska Development's portfolio company OssDsign announces that its latest product Cranioplug has received 510(k) clearance by the FDA, which allows marketing and sales of the product in US. The implant is the first product of its kind in the US market. Cranioplug is an implant used during neurosurgical procedures. The product is intended to cover and plug holes drilled into the skull during surgery and to reattach cranial bone removed during surgery. Cranioplug resorbs and is replaced with bone during the healing process. Anders Lundqvist, CEO of OssDsign, said: "Receiving clearance for Cranioplug is an important step for OssDsign. This motivates us to increase our presence in the US market and continue to build our US organization throughout 2018 and beyond. The regenerative features of OssDsign's calcium phosphate composition are now getting recognized, and it's our mission to turn them into real benefits for patients, surgeons and hospital systems."

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum